{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":1,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":25,"n_cols":5,"rows_kept":25,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[3,2,3,3],[7,2,7,3],[8,2,8,3],[9,2,9,3],[13,2,13,3],[14,2,14,3],[18,2,18,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNINA9910455372303321"]
[null,null,"Titolo",null,"Women and health research [[electronic resource] ] : ethical and legal issues of including women in clinical studies . Volume I / / Anna C. Mastroianni, Ruth Faden, and Daniel Federman, editors ; Committee on the Ethical and Legal Issues Relating to the Inclusion of Women in Clinical Studies, Division of Health Sciences Policy, Institute of Medicine"]
[null,null,"Pubbl/distr/stampa",null,"Washington, D.C., : National Academy Press, 1994"]
[null,null,"ISBN",null,"1-280-19580-0"]
[{"$nulls":4},"9786610195800"]
[{"$nulls":4},"0-309-58621-6"]
[{"$nulls":4},"0-585-02366-2"]
[null,null,"Descrizione fisica",null,"1 online resource (288 p.)"]
[null,null,"Disciplina",null,"174/.28"]
[null,null,"Soggetti",null,"Women - Health and hygiene - Research - Moral and ethical aspects"]
[{"$nulls":4},"Human experimentation in medicine - Moral and ethical aspects"]
[{"$nulls":4},"Human experimentation in medicine - Law and legislation"]
[{"$nulls":4},"Electronic books."]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Note generali","Description based upon print version of record."]
[null,null,null,"Nota di bibliografia","Includes bibliographical references and index."]
[null,null,"Nota di contenuto",null,"\"\"WOMEN AND HEALTH RESEARCH\"\"; \"\"Copyright\"\"; \"\"Preface\"\"; \"\"Acknowledgments\"\"; \"\"Contents\"\"; \"\"Executive Summary\"\"; \"\"WOMEN'S PARTICIPATION IN CLINICAL STUDIES\"\"; \"\"JUSTICE IN CLINICAL STUDIES: GUIDING PRINCIPLES\"\"; \"\"SCIENTIFIC CONSIDERATIONS\"\"; \"\"SOCIAL AND ETHICAL CONSIDERATIONS\"\"; \"\"LEGAL CONSIDERATIONS\"\"; \"\"RISKS TO REPRODUCTION AND OFFSPRING\"\"; \"\"IMPLEMENTATION\"\"; \"\"The Investigator\"\"; \"\"Immediate Actions\"\"; \"\"As Soon as Feasible\"\"; \"\"The IRB\"\"; \"\"Immediate Actions\"\"; \"\"As Soon as Feasible\"\"; \"\"IRGs and TEGs\"\"; \"\"Immediate Actions\"\"; \"\"As Soon as Feasible\"\""]
[{"$nulls":4},"\"\"Scientific Advisory Councils\"\"\"\"As Soon as Feasible\"\"; \"\"NIH\"\"; \"\"Immediate Actions\"\"; \"\"As Soon as Feasible\"\"; \"\"1 Introduction\"\"; \"\"MANDATE AND SCOPE OF STUDY\"\"; \"\"STRUCTURE OF REPORT\"\"; \"\"DEFINITIONS\"\"; \"\"THE DRUG DEVELOPMENT PROCESS\"\"; \"\"REFERENCES\"\"; \"\"2 Women's Participation in Clinical Studies\"\"; \"\"HISTORICAL BACKGROUND\"\"; \"\"Evolution of Protectionist Policies\"\"; \"\"Research Abuses\"\"; \"\"Responses to Fetal Injury\"\"; \"\"Advent of Inclusionary Policies\"\"; \"\"NIH Office of Research on Women's Health and "]
[{"$nulls":4},"Recent Changes\"\"; \"\"CURRENT STATUS\"\"; \"\"Studies of Heart Disease and AIDS\"\""]
[{"$nulls":4},"\"\"Heart Disease\"\"\"\"AIDS\"\"; \"\"Women of Childbearing Age in Early Phases of Drug Trials\"\"; \"\"Clinical Trial Registries\"\"; \"\"CONCLUSIONS AND RECOMMENDATIONS\"\"; \"\"NOTES\"\"; \"\"REFERENCES\"\"; \"\"3 Justice in Clinical Studies: Guiding Principles\"\"; \"\"CONCEPTIONS OF JUSTICE\"\"; \"\"The Distributive Paradigm\"\"; \"\"Application to Clinical Studies\"\"; \"\"Justice and the Research Agenda: Oppression and Power\"\"; \"\"LIMITS TO THE REQUIREMENTS OF JUSTICE\"\"; \"\"STATEMENT OF GUIDING PRINCIPLES\"\"; \"\"REFERENCES\"\"; \"\"4 Scientific Considerations\"\"; \"\"EVIDENCE OF GENDER DIFFERENCES\"\""]
[{"$nulls":4},"\"\"Body Size, Composition, and Metabolism\"\"\"\"Gender and Aging\"\"; \"\"Behavioral and Psychosocial Differences\"\"; \"\"Endogenous Hormones\"\"; \"\"Pregnancy and Lactation\"\"; \"\"Exogenous Hormones\"\"; \"\"Hormonal Contraceptives\"\"; \"\"Menopause and Hormone Replacement\"\"; \"\"METHODOLOGICAL IMPLICATIONS\"\"; \"\"Clinical Studies\"\"; \"\"Clinical Trials\"\"; \"\"External and Internal Validity\"\"; \"\"Homogeneity Versus Heterogeneity\"\"; \"\"Exclusions from Trials\"\"; \"\"Subgroup Analysis\"\"; \"\"Alternatives to Clinical Trials\"\"; \"\"CONCLUSIONS AND RECOMMENDATIONS\"\"; \"\"REFERENCES\"\"; \"\"5 Social and Ethical Considerations \"\""]
[{"$nulls":4},"\"\"SCIENCE AND OBJECTIVITY\"\"\"\"QUESTIONS OF GENDER\"\"; \"\"Male Bias\"\"; \"\"Male Norm\"\"; \"\"QUESTIONS OF RACE AND ETHNICITY\"\"; \"\"The Diversity of Women\"\"; \"\"Constructions of Race and Ethnicity\"\"; \"\"Biology or Sociology?\"\"; \"\"Faulty Constructions of Ethnicity\"\"; \"\"One Model of Health Does Not Fit All Groups\"\"; \"\"Context and Meaning of Research in Different Communities\"\"; \"\"RECRUITMENT AND RETENTION ISSUES\"\"; \"\"Feasibility, Logistics, and Cost\"\"; \"\"Outreach and Access\"\"; \"\"Community Attitudes Towards Research\"\"; \"\"Appropriateness of Participation\"\"; \"\"PROTECTION OF RESEARCH PARTICIPANTS\"\""]
[{"$nulls":4},"\"\"Potential for Exploitation\"\""]